[]



Yüklə 245,71 Kb.
tarix30.04.2018
ölçüsü245,71 Kb.
#40512


記錄

編號


4402

狀態

NC091FJU00255004

助教

查核





索書






學校

名稱


輔仁大學

系所

名稱


食品營養學系

舊系

所名






學號

488446042

研究

(中)



陳曉錚

研究

(英)



Hsiao-Cheng Chen

論文

名稱

(中)



乳酸菌抑制亞硝胺致突變性之研究

論文

名稱

(英)



Inhibitory effect of lactic acid bacteria on the mutagenicity of nitrosamine

其他

題名





指導

教授

(中)



丘志威 博士

指導

教授

(英)






校內

全文

開放



日期

不公開


















































































































































































































































校外

全文

開放



日期

不公開

全文

不開

放理








電子

全文

送交



圖.


同意

國圖

全文

開放



期.


2003.01.09

檔案

說明


電子全文

電子

全文


01

學位

類別


碩士

畢業

學年



91

出版






語文



中文

關鍵

(中)



乳酸菌 亞硝胺 安氏試驗法 抗致突變性

關鍵

(英)






摘要

(中)


本研究旨在探討亞硝胺濃度及乳酸菌類別之致突變性,乳酸菌濃度及培養

基上清液對亞硝胺抗致突變性的影響,及評估市售乳酸菌發酵乳對亞硝胺

之抗致突變活性。 亞硝胺對 Salmonella typhimurium TA98 及 TA100 致突變







性的研究顯示,其使用劑量低於 10 mg/plate,對 TA98 並無致突變性;N-

nitrosodimethylamine (NDMA)及 N-nitrosodiethylamine (NDEA)使用劑量於 5

mg/plate 以下時,對 TA100 亦不具致突變性。然而,N-nitrosopyrrolidine

(NPYR)於 S-9 混合物作用下,在選取的濃度範圍(0.5~5 mg/plate)內對

TA100 的致突變性隨著濃度的上升有增加的趨勢。Lactobacillus spp.、

Bifidobacterium longum CCRC14634 和 Streptococcus thermophilus CCRC14087

等五株菌對 TA100 並無致突變能力,且 pH 值亦無影響。 五株乳酸菌的培

養液均能有效抑制 NPYR (4 mg/plate)的致突變性,其中抑制率最高者為

Lactobacillus casei CCRC14073 的 54.4%,L. bulgaricus CCRC14007、B.

longum CCRC14634、L. acidophilus CCRC10695 次之。僅 L. casei CCRC14073

培養液經離心後之上清液對 NPYR 有輕度的抗致突變性。而乳酸菌菌體對

NPYR 的抗致突變力在菌體濃度為 109 CFU/mL 時效果較顯著,其中 L.

casei CCRC14073、L. bulgaricus CCRC14007、B. longum CCRC14634 及 S.

thermophilus CCRC14087 有較佳抑制率,介於 16.7%~26.3%之間,L.

acidophilus CCRC10695 則無明顯抑制現象。此外,部分市售含活性乳酸菌

發酵乳對 NPYR 之致突變性亦有不錯的抑制效果,抑制率達

19.1%~29.7%。


摘要

(英)


The objectivess of this study were to investigate (1) the mutagenicity of various

concentrations of nitrosamines and different lactic acid bacteria, (2) the

antimutagenicity of lactic acid bacteria concentrations and filtrates obtained from

cell suspensions of lactic acid bacteria against nitrosamines, (3) the antimutagenic

activity of commercial yogurt containing lactic acid bacteria against nitrosamines.

The mutagenic activites of three N-nitrosamines were tested using Salmonella

typhimurium TA98 and TA100. N-nitrosamine was not mutagenic to TA98 when

the concentrations were below 10 mg/plate. N-nitrosodimethylamine (NDMA) and

N-nitroso- diethylamine (NDEA) also showed no mutagenicity to TA100 when the

concentrations were below 5 mg/plate. However, the mutagenicity of N-

nitrosopyrrolidine (NPYR) in the presence of S9 mix with increasing concentration

in the range of 0.5~5 mg per plate. In all of the selected 5 strains, Lactobacillus

spp., Bifidobacterium longum CCRC14634, and Streptococcus thermophilus

CCRC14087 were not mutagenic to TA100, and the pH had no effect. All of the

lactic acid bacterial growth broths examined moderately inhibited the mutagenicity

of NPYR (4 mg/plate). Lactobacillus casei CCRC14073 showed the highest

inhibition of 54.4%, and the mutagenicity of NPYR was inhibited to a smaller

extent by each culture of L. bulgaricus CCRC14007, B. longum CCRC14634 and

Lactobacillus acidophilus CCRC10695. Most supernatant of lactic acid bacterial

growth broths tested had no antimutagenic effect against NPYR, whereas L. casei

CCRC14073 showed weak antimutagenic activity. Lactic acid bacterial cells when

presence at concentration of 109 CFU/mL showed higher antimutagenic activity

against NPYR. Among the strains examined, L. casei CCRC14073, L. bulgaricus

CCRC14007, B. longum CCRC14634 and S. thermophilus CCRC14087 exhibited

higher inhibition percentage from 16.7 to 26.3%. In contrast, L. acidophilus

CCRC10695 did not show appreciable levels of inhibition. In addition, some

commercial yogurts containing viable lactic acid bacteria showed inhibitory effects


in the range of 19.1~29.7% as well against the mutagenicity of NPYR

目 錄 頁次 第一章 緒言……………………………………………………… 1

第二章 文獻回顧………………………………………………… 3 一、 影響

亞硝胺生成的因素………………………………… 3 (一) 硝酸鹽及亞硝酸鹽

含量………………………………… 3 (二) pH

值……………………………………………….……. 5 (三) 二級胺種

類……………………………………………… 5 (四) 加工方式及食品組成

份………………………………… 7 (五) 微生物作

用……………………………………………… 7 二、 食品中亞硝胺的含

量…………………………………… 10 (一) 醃肉中的亞硝胺含

量…………………………………… 10 (二) 魚類製品的亞硝胺含

量………………………………… 12 (三) 脫脂乳粉及黃豆製品的亞硝胺含

量…………………… 14 (四) 蔬菜的亞硝胺含

量……………………………………… 14 (五) 酒精飲料的亞硝胺含

量………………………………… 14 三、 亞硝胺的毒

性…………………………………………… 17 (一) 急性

毒…………………………………………………… 17 (二) 致癌性

毒………………………………………………… 18 四、 食品中抑制亞硝胺

突變的成分………………………… 20 (一) 維生素

C………………………………………………… 20 (二) 維生素

E……………………………………………….... 22 (三) 酚類化合

論文

目次

物……………………………………………… 23 (四) 類胡蘿蔔



素……………………………………………… 25 (五) 其他化合

物……………………………………………… 25 (六) 微生

物…………………………………………………… 26 五、 乳酸菌簡

介……………………………………………… 27 六、 乳酸菌與健

康…………………………………………… 27 (一) 構成益生菌的要

件……………………………………… 30 (二) 腸道菌與人類關

係……………………………………… 30 (三) 益生菌對人體的益

處…………………………………… 34 第三章 材料與方

法……………………………………………… 40 一、 實驗材

料………………………………………………… 40 (一) 試驗菌

株………………………………………………… 40 (二) 亞硝胺種

類……………………………………………… 40 (三) 培養

基…………………………………………………… 40 (四) 化學藥

品………………………………………………… 40 (五) 市售含乳酸菌發酵

乳..…………………………………. 41 二、 儀器設

備………………………………………………… 42 三、 實驗方法及步

驟………………………………………… 42 (一) 乳酸菌培養液製

備……………………………………… 42 (二) 不同 pH 值乳酸菌溶液的製

備…………………………. 42 (三) 不同 pH 值緩衝溶液的製

備……………………………. 43 (四) 亞硝胺標準品的製

備…………………………………… 43 (五) Ames test 試驗原

理……………………………………... 44 () S. typhimuriumTA98 TA100

之培養及製備……….... 44 (七) S. typhimuriumTA98 及 TA100 基因型態之確

認…….... 45 (八) 亞硝胺的致突變性試驗………………………..………. 49

(九) 乳酸菌的致突變性試驗………………………………… 50 (十) 乳酸菌

對亞硝胺的抗致突變性試驗.…………………... 51 (十一) 市售含乳酸菌發

酵乳抑制亞硝胺致突變性調查….…... 52 六、 統計分

析………………………………………………… 52 第四章 結果與討

論……………………………………………… 53 一、 試驗菌株基因型態之

確認……………………………… 53 二、 亞硝胺濃度對 S. typhimurium 致

突變性的影響………. 53 三、 乳酸菌對 S. typhimurium 生長的影

響…………………. 64 四、 乳酸菌培養液對亞硝胺之抗致突變

性………………… 69 五、 乳酸菌上層液對亞硝胺之抗致突變

性………………… 71 六、 乳酸菌菌體對亞硝胺之抗致突變

性…………………… 71 七、 市售含乳酸菌發酵乳抑制亞硝胺致突變性調

查……… 74 第五章 結論………………………………………………………

78 參考文獻 …………………………………………………………… 80 附錄

一、 市售含乳酸菌發酵乳樣品……………………………… 92 圖 目 錄 頁

次 圖一、 亞硝胺生成機制之通式……………………………………. 4 圖

二、 大腸桿菌懸浮液和米麴菌菌叢中 DMNA 和亞硝酸鹽生成的情

形………………………………………………………. 11 圖三、 改變抑制劑

和亞硝酸鹽的莫耳濃度比例對二甲胺生成 NDMA 的影

響……………………………………………… 24 圖四、 不同部位消化道之

腸道菌分布情形………………………. 32 圖五、 腸道菌隨人類年齡變化之

改變情形…………………….… 33 圖六、 雙叉乳酸桿菌培養液之 pH 調整

對大腸桿菌生長的影響…….. 36 表 目 錄 頁次 表一、 各種二級胺之 pKa

值及最適於亞硝化之 pH 值……….. 6 表二、 不同加工方式對培根中

nitrosopyrrolidine 生成量的影響 8 表三、 餵食無菌老鼠及普通老鼠含脯胺

酸及亞硝酸鈉的飲用水後,排泄物中 NPRO 的存在情

形……………………. 9 表四、 傳統豬肉培根及仿培根產品之揮發性亞硝

胺含量…….. 13 表五、 黃豆製品中 NDMA 的含

量……………………………… 15 表六、 各式酒精性飲料中 N-

nitrosodimethylamine 的含量……. 16 表七、 亞硝胺對 BD 大白鼠之半數致

死劑量及其目標器官….. 19 表八、 亞硝基化合物致癌之目標器

官………………………….. 21 表九、 由 Dadih 發酵乳分離之乳酸菌對 N-

nitroso-dimethyl-amine(NDEA)致突變性的抑制情形…………………….. 28 表

十、 Bifidobacterium longum 胞內萃取液去除亞硝胺的百分

比………………………………………………………….. 29 表十一、 乳酸

菌對病原菌的抑制情形…………………………..… 35 表十二、 安氏試驗

(Ames Test)系統之 TA 菌株基因型…………. 46 表十三、 Salmonella

typhimurium TA98 及 TA100 之基因型態檢測 54 表十四、 NDMA


Salmonella typhimurium TA98 之致突變性…. 56 表十五、 NDEA
Salmonella typhimurium TA98 之致突變性….. 57 表十六、 NPYR
Salmonella typhimurium TA98 之致突變性…… 58 表十七、 NDMA
Salmonella typhimurium TA100 之致突變性… 60 表十八、 NDEA
Salmonella typhimurium TA100 之致突變性…. 61 表十九、 NPYR




Salmonella typhimurium TA100 之致突變性…. 62 表二十、 乳酸菌生長過之

培養液對 Salmonella typhimurium TA100 之致突變

性………………………………………. 65 表二十一、 乳酸菌上層液對

Salmonella typhimurium TA100 之致突變

性………………………………………………………. 66 表二十二、 乳酸菌

菌體對 Salmonella typhimurium TA100 之致突變

性…………………………………………………………. 67 表二十三、 乳酸

菌生長過之培養液對 NPYR 之抗致突變性………. 70 表二十四、 乳酸菌上

層液對 NPYR 之抗致突變性…………………. 72 表二十五、 乳酸菌菌體對

NPYR 之抗致突變性……………………. 73 表二十六、 市售發酵乳對

NPYR 之抗致突變性……………………. 76


參考

文獻


參考文獻 王有忠。1993。食品安全。pp.180-191。華香園出版社。台北

市。 王果行、丘志威、章樂綺、盧義發、蔡敬民。1992。普通營養學。

pp. 56-81。匯華出版社。台北市。 尤新。2001。機能性發酵製品。pp. 439-

467。藝軒出版社。台北市。 行政院衛生署。1999。中華民國公共衛生年

報。行政院衛生署企劃處。台北市。 呂鋒洲、徐東展。1996。發酵大麥

清除超氧陰離子自由基能力的研究。食品科學 23(1): 10-19。 沈明來。

1993。試驗設計學。九洲圖書出版社。台北市。 林仁混。1994。食物與癌

症。聯經出版社。台北市。 林松洲。1993。食物與癌症。毫峰出版社。

台北市。 林松筠。1987。醃肉中亞硝酸鹽與肉毒桿菌中毒。食品工業

19(9): 16-27。 吳思敬、顏國欽。1995。桑葉甲醇萃取物抗致突變性之研

究。食品科學 22(1): 59-68。 陳清泉。1999。兒茶素之抗癌及抗體瘤效

應。食品工業 31(9): 1-15。 黃建榕。1996。乳酸菌之蛋白分解物對

Bifidobacterium longum 生育性之影響。中國畜產學會會誌 25(2): 221-230。

張康榮。1994。食品衛生法規概論。p. 264。三民書局。台北市。 楊媛

絢。1998。原生保健性菌種與益菌助生質之應用。食品工業 30(2): 11-22。

經濟部中央標準局。1996。發酵乳。中國國家標準,CNS 3058 N5095。 蔡

英傑。1998。乳酸菌與益生菌。生物產業 9(2): 98-104。 鄭信男、劉黃惠

珠、李輝、蔡順仁。1998。辣椒類胡蘿蔔之抗氧化性與對食物致突變物

IQ 之抗突變性間之相關性。中華營誌 23: 357-375。 顏國欽。1997。食品

安全學。pp. 81-98。藝軒出版社。台北市。 蘇和平、田志華、林慶文。

1992。市售發酵乳類製品品質成分之調查。中國畜牧學會會誌 21(4): 421-

428。 Amonkar AJ, Nagabhushan M, D’Souza VA, Bhide SV. 1986.

Hydroxychavicol: a new phenolic antimutagen from betal leaf. Food Chem Toxicol

24: 1321-1324. Armijo R, Orellana M, Medina E, Coulson AH, Sayre JW, Detels R.

1981. Epidemiology of gastric cancer in Chile: I. case control study. Int J Epidemiol

10: 53-56. Atawodi SE, Lamorde AG, Spiegelhalder B, Preussmann R. 1995.

Nitrosation of Nigerian medicinal plant preparations under: ‘chemical’ and

‘stimulated’ gastric condition. Food Chem Toxic 33: 43-48. Ayanaba A,

Alexander M. 1973. Microbial formation of nitrosamines in vitro. Appl Microbiol

25: 862-868. Barnes JM, Magee PN. 1954. Some toxic properties of

dimethylnitrosamine. Brit J Ind Med 11:167-174. Beatriz M, Gloria A, Barbour JF,

Scanlan RA. 1997. Volatile nitrosamines in fried bacon. J Agric Food Chem 45:

1816-1818. Bharucha KR, Cross CK, Rubin LJ. 1979. Mechanism of N-


nitrosopyrrdidine formation in bacon. J Agric Food Chem 27: 63-69. Bodana AR,

Rao DR. 1990. Antimutagenic activity of milk fermented by Streptococcus

thermophilus and Lactobacillus bulgaricus. J Dairy Sci 73(12): 3379-3384. Bu-

Abbas A, Clifford MN, Walker R, Ioannides C. 1994. Marked antimutagenic

potential of aqueous green tea extracts: mechanism of action. Mutagenesis 9: 325-

331. Bu-Abbas A, Copeland E, Clifford MN, Walker R, Ioannides C. 1997.

Fractionation of green tea extracts: correlation of antimutagenic effect with flavanol

content. J Sci Food Agric 75: 453-462. Cho IC, Bratzler LJ. 1970. Effect of sodium

nitrite on flavor of cured pork. J Food Sci 35: 668-671. Dahl AR. 1985.

Mutageniicity of some dialkylnitrosamines, cyclic nitrosamines and N,N-

diethanolnitrosamine in Salmonella typhimurium with rat and rabbit nasal, lung and

liver S9 homogenates. Mut Res 158(3):141-147. Dawson MC, Elliott DC, Elliott

WH, Jones KM. 1986. Data for Biochemical Research. p. 432. Oxford Scuence

Publications. South Australia. Dich J, Jarrvinen RR, Knekt P, Penttila PL. 1996.

Dietary intakes of nitrate, nitrite and NDMA in the Finnish mobile clinic health

examination survey. Food Additives and Contam 13: 541-552. Duax WL, Ghosh D.

1997. Structure and function of steroid dehydrogenases involved in hypertension,

fertility, and cancer. Steroids 62: 95-100. Eckmann L, Kagnoff MF, Fierer J. 1995.

Intestinal epithelial cells as watchdogs for the immune system. Trends Microbiol

3(3): 118-120. Eichholzer M, Gutzwiller F. 1998. Dietary nitrates, nitrites, and N-

nitroso compounds and cancer risk: a review of the epidemiologic evidence. Nutr

Rev 56: 95-105. Fazio T, Havery DC. 1982. Volatile N-nitrosamines in direct flame

dried processed foods. In “N-Nitroso Compounds: Occurrence and Biological

Effects,” H Bartsch, IK O’Neill, M Castegnarro, M Okada (ed), p. 227. Int

Agency for Res On Cancer, Lyon, France. Fiddler W, Piotrowski EG, Pensabene

JW, Doern RC, Wasserman AE. 1972. Effect of sodium nitrite concentration of N-

nitrosodimethylamine formation in frankfurters. J Food Sci 37: 668-669. Fiddler W,

Pensabene JW, Piotrowski EG, Phillips JG, Keating J, Mergens WJ, Newmark HL.

1978. Inhibition of formation of volatile nitrosamine in fried bacon by use of cure-

solubilized α-tocopherol. J Agric Food Chem 26: 653-656. Fiddler W, Pensabene

JW, Gates RA, Hale M, Jahncke M. 1992. N-nitrosodimethylamine formation in

cooked frankfurters containing Alaska Pollock (Theragra chalcogramma) mince and

surimi. J Food sci 57: 569-595. Fujita K, Kamataki T. 2001. Role of human

cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines:

application of genetically enginerred Salmonella typhimurium YG7108 expressing

each form of CYP together with human NADPH-cytochrome P450 reductase. Mut

Res 483: 35-41. Gibsons, GR, Roberfroid MB. 1995. Dietary modulation of the

human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):

1401-1412. Gichner T, Velemínský J. 1988. Mechanisms of inhibition of N-nitro

compounds-induced mutagenicity. Mut Res 202: 325-334. Goff EU, Fine DH. 1979.

Analysis of volatile N-nitrosamine in alcoholic beverages. Food Cosmet Toxicol 17:

568-573. Goldin BR. 1998. Health benefits of probiotics. Br J Nutr 80(Suppl 2):

S203-S207. Goldin BR, Gorbach SL. 1984. The effect of milk and lactobacillus



feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39: 756-761.

Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. 1980. Effect of diet and

Lactobacillus acidophilus supplements on human fecal bacterial systems. J Natl

Cancer Inst 645: 255-261. Gonzalez SN, Apella MC, Romero NC, Macias MEN,

Oliver G. 1993. Inhibition of enteropathogens by lactobacilli strains used in

fermented milk. J Food Prot 56: 773-776. Grill JP, Crociani J, Ballongue J. 1995.

Effect of bifidobacteria on nitrites and nitrosamines. Lett Appl Microbiol 20: 328-

330. Hakura A, Suzuki S, Satoh T. 1999. Advantage of the use of human liver S9 in

the Ames test. Mut Res 438: 29-36. Havery DC, Fazio T. 1985. Human exposure to

nitrosamines from foods. Food Technol 39(1): 80-83. Havery DC, Hotchkiss JH,

Fazio T. 1981. Nitrosamines in malt and malt beverages. J Food Sci 46: 501-505.

Havery DC, Hotchkiss JH, Fazio T. 1982. Rapid determination of volatile N-

nitrosamines in nonfat dry milk. J Dairy Sci 65: 182-185. Hawksworth GM, Hill

MJ. 1972. Bacteria and the N-nitrosation of secondary amines. Biochem Acta 106:

520-526. Helser MA, Hotchkiss JH. 1994. Comparison of tomato phenolic and

ascorbate fractions on the inhibition of N-nitroso compound formation. J Agric

Food Chem 42: 129-132. Hill MJ. 1991. Nitrates and Nitrites in Food and Water,

MJ Hill (Ed), Simon and Schuster Int. Group Co., England. Hoijer MA, Melief MJ,

van Helden-Meeuwsen CG, Eulderink F, Hazenberg MP. 1995. Detection of

muramic acid in a carbohydrate fraction of human spleen. Infect Immun 63(5):

1652-1657. Hoover DG. 1993. Bifidobacteria: activity and potential benefits. Food

Technol 47: 120-124. Hosataka M, Hashimoto H, Morita H, Chiba M. 1992a.

Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N’-

nitro-N- nitrosoguanidine. J Dairy Sci 75(4): 976-981. Hosataka M, Hashimoto H,

Morita H, Chiba M, Hosono A. 1992b. Studies on antimutagenic effect of milk

cultured with lactic acid bacteria on the Trp-P2-induced mutagenicity to TA98

strain of Salmonella typhimurium. J Dairy Res 59: 543-549. Hosono A, Kashina T.

1986. Antimutagenic properties of lactic acid-cultured milk on chemical and fecal

mutagens. J Dairy Sci 69(9): 2237-2242. Hosono A, Wardojo R, Otani H. 1990.

Inhibitory effects of lactic acid bacteria from fermented milk on the mutagenicities

of volatile nitrosamines. Agric Biol Chem 57: 1639-1643. Huang DP, Ho JHC.

1981. Volatile nitrosamines in salt-preserved fish before and after cooking. Food

Cosmet Toxicol 19: 167-171. Huarte-Mendicoa JC, Astiasaran I, Bello J. 1997.

Nitrate and nitrite levels in fresh and frozen broccoli: effect of freezing and cooking.

Food Chem 58: 39-42. Hughes DB, Hoover DG. 1995. Viability and enzymatic

activity of bifidobacteria in milk. J Dairy Sci 78: 268-276. Huis in’t Veld JHJ,

Havenaar R. 1991. Probiotics and health in man and animal. In ’Probiotics-fact or

fiction?’ J Chem Tech Biotechnol 51(4): 562-567. Hull RR, Conway PL, Evans

AJ. 1992. Probiotic foods: a new opportunity. Food Australia 44(3): 112-113.

Ibrahim SA, Bezkorovainy A. 1993. Inhibition of Escherichia coli by bifidobacteria.

J Food Prot 56: 713-715. Ikken Y, Cambero I, Marin M, Martinez A, Haza AI,

Morales P. 1998. Antimutagenic effect of fruit and vegetable aqueous extracts

against N-nitrosamines evaluated by the Ames test. J Agric Food Chem 46: 5194-

5200. Kansmuller S, Friesen MD, Holme JA, Alexander J, Sanyal R, Kassie F,

Barstsch H. 1996. Effect of phenethyl isothiocyanate on metabolism and on

genotoxicity of dimethylnitrosamine and 2-amino-1-methyl-6- phenylimidazo-[4,5-

beta] pyridine(PhIP). Mut Res 350: 93-102. Kikugawa K, Hakamada T, Tasunuma

M, Kurechi T. 1983. Reduction of p-hydroxycinnamic acids with nitrite and its

relevance to nitrosamine formation. J Agric Food Chem 31: 780-785. Klaver FAM,

van der Merr R. 1993. The assumed assimilation of cholesterol by lactobacilli and

Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl

Environ Microbiol. 59: 1120-1124. Kolb E, Haug M, Janzowski C, Vetter A,

Eisenbrand G. 1997. Potential nitrosamine formation and its prevention during

biological denitrification of red beet juice. Food Chem Toxicol 35: 219-224.

Krinsky NI. 1989. Antioxidant function of cartenoid. Free Rad Biol Med 7: 617-

635. Laitinen S, Virtanen SM, Räsänen L, Penttilä PL. 1993. Calculated dietary

intakes and nitrite by young finns. Food addit contam 10(4): 469-477. Langenbach

R, Leavitt S, Hix C, Sharief Y, Allen JW. 1986. Rat and hamster hepatocyte-

mediated induction of SCEs and mutation in V79 cells and mutation of Salmonella

by aminofluorene and dimethylnitrosamine. Mut Res 161: 29-37. Lankaputhra

WEV, Shah NP. 1998. Antimutagenic properties of probiotic bacteria and of organic

acids. Mut Res 397: 169-182. Lathia D, Blum A. 1989. Role of vitamin E as nitrite

scavenger and N-nitrosamine inhibitor: a review. Int’l J Vit Nutr Res 59: 430-438.

Lee YK, Salminen S. 1995. The coming of age of probiotics. Trend Food Sci

Technol 6: 241-245. Lijinsky W, Andrews AW. 1983. The superiority of hamster

liver microsomal fraction for activating nitrosamines to mutagens in Salmonella

typhimurium. Mut Res 111: 135-144. Lijinsky W, Reuber MD. 1981. Comparative

carcinogenicity of some aliphatic nitrosamines in Fischer rats. Cancer Lett 14: 296-

302. Maron DM, Ames BN. 1983. Revised methods for the Salmonella

mutagenicity test. Mut Res 113: 173-215. Meghrous J, Euloge P, Junelles AM,

Ballongue J, Petitclemange H. 1990. Screening of Bifidobacterium strains for

bacteriocin production. Biotechnol Lett 12: 575-580. Mirvish SS. 1975. Formation

of N-nitriso compounds: chemistry, kinetics, and in vivo occurrence. Toxicol Appl

Pharmacol 31: 325-351. Mitsuoka T, Kaneuchi C. 1997. Ecology of the

bifidobacteria. Am J Clin Nutr 30: 1799-1810. Miyao S, Ogawa T. 1990. Effect of

surrounding factors on nitrite production by bacteria related to fermented pickles. J

Jpn Soc Food Sci Technol 37: 670-675. [In FSTA (CD-ROM), Accession number

91-05-T0035, Int Food Inf Serv, Reading, UK.] Molder HW, McKellar RC,

Yaguchi M. 1990. Bifidobacteria and bifidogenic factors. Can Inst Food Sci

Technol J 23(1): 29-41. Mortelmans K, Zeiger E. 2000. The Ames

Salmonella/microsome mutagenicity assay. Mut Res 455: 29-60. Nabrzyski M,

Grjewska R. 1994. The content of nitrate and nitrite in fruits, vegetables and in

some other foodstuffs. Roczniki Panstwowego Zakladu Higieny 45: 167-180. [In

FSTA (CD-ROM), Accession number 95-10-A0129, Int Food Inf Serv, Reading,

UK.] Nadathur SR, Gould SJ, Bakalinsky AT. 1994. Antimutagenicity of fermented

milk. J Dairy Sci 77(11): 3287-3295. Naidu AS, Bidlack WR, Clemens RA. 1999.

Probiotic spectra of lactic acid bacteria. Crit Rev Food Sci Nutr 38: 13-126.

Nakazawa YA, Hosono A, Howells W. 1992. Functions of fermented milk. Elsevier

Applied Science, N.Y. Oliveira CP, Gloria MBA, Barbour JF, Scanlan RA. 1995.

Nitrate, nitrite and volatile nitrosamines in whey-coontaining food procducts. J

Agric Food Chem 43: 967-969. Pearson AM, Sleight SD, Brooks RI, Gray JI. 1993.

Further studies on N-nitrosopyrrolidine and its precursors: effect of ascorbic acid

and vitamin E on tumor development in mice as related to consumption of cured

meat. Meat Sci 33: 111-120. Pensabene JW, Fiddler W, Gates RA, Fagan JC,

Wasserman AE. 1974. Effect of frying and other cooking conditions on

nitrosopyrrolidine formation in bacon. J Food Sci 39: 314-316. Pool-Zobel BL,

Bertram B, Knoll M, Lammbertz R, Neudecker C, Schillinger U, Schmezer P,

Holzapfel WH. 1993. Antigenotoxic properties of lactic acid bacteria in vivo in the

gastrointestinal tract of rats. Nurt cancer 20(2): 271-281. Prival MJ, King VD,

Sheldon AT. 1979. The mutagenicity of dialkyl nitrosamines in the Salmonella plate

assay. Environmental Mutagenesis 1: 95-104. Raineri R, Poiley JA, Andrews AW,

Pienta RJ, Lijinsky W. 1981. Greater effectiveness of hepatocyte and liver S9

preparations from hamsters than rat in activating N-nitroso compounds to

metabolites mutagenic to Salmonella. J Natl Cancer Inst 67(5):1117-1122. Rasic JL,

Kurmann JA. 1983. Bifidobacteria and their role. Birkhauser verlag, Basel. Reddy

SK, Gray JI, Price JF, Wilkens WF. 1982. Inhibition of nitrosopyrrolidine in dry

cured bacon by α-tocopherol-coated salt system. J Food Sci 47: 1598-1602. Renner

HW, Münzner R. 1991. The possible role of probiotics as dietary antimutagens. Mut

Res 262: 239-245. Robach MC, Owens JL, Paquette MW, Sofos JN, Busta FF.

1980. Effects of various concentrations of sodium nitrite and potassium sorbate on

nitrosamine formation in commercially prepared bacon. J Food Sci 45: 1280-1284.

Rowland IR, Grasso P. 1975. Degradation of N-nitrosamines by intestinal bacteria.

Appl Microbiol. 29: 7-12. Sanderson JE, Consaul JR, Lee K. 1991. Nitrate analysis

in meats: comparison of two methods. J Food Sci 56: 1123-1124. Scanlan RA.

1983. Formation and occurrence of nitrosamines in food. Cancer Res 43(Suppl):

2435S-2440S. Sen NP, Iyengar JR, Donaldson BA, Panalaks T. 1974. Effects of

sodium nitrite concentration on the formation and dimethylnitrosamine infried

bacon. J Agric Food Chem 22: 540-541. Sen NP, Donaldson B, Seaman S, Iyengar

JR, Miles WF. 1976. Inhibition of nitrosamine formation in fried bacon by propyl

gallate and L-ascorbyl palmitate. J Agric Food Chem 24: 397-401. Sen NP, Tessier

L, Seaman SW, Baddoo PA. 1985. Volatile and nonvolatile nitrosamines in fresh

and the effect of deliberate nitrosation under simulated gastric condition. J Agric

Food Chem 33: 264-268. Shah NP, Lankaputhra WEV, Britz ML, Kyle WSA. 1995.

Survival of Lactobacillus acidophilus and Bifidobacterium bifidum in commercial

yoghurt during refrigerated storage. Int Dairy Journal 5: 515-521. Shahani KM,

Friend BA, Bailey PJ. 1983. Antitumor activity of fermented colostrum and milk. J

Food Prot 46: 385-386. Shahidi F, Synowiecki J, Sen NP. 1995. N-nitrosamine in

nitrite-cured chicken-seal salami. J Food Prot 58: 446-448. Shenoy NR, Choughuley

AS. 1989. Effect of certain plant phenolics on nitrosamine formation. J Agric Food

Chem 37: 721-725. Shenoy NR, Choughuley AS. 1992. Inhibitory effect of diet

related sulphydryl compounds on the formation of carcinogenic nitrosamines.

Cancer Lett 65: 227-232. Simenhoff ML, Dunn SR, Zollner GP, Fitzpatrick MED,

Emery SM, Sandine WE, Ayres JW. 1996. Biomodulation of the toxic and

nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease

using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 22: 92-96.

Simpson KL. 1987. Relative value of carotenoids as a precursors of vitamin A. Proc

Nutr Soc 42: 7-17. Skrypec DJ, Gray JI, Mandagere AK, Booren AM, Pearson AM,

Cuppett SL. 1985. Effect of bacon composition and processing on N-nitrosamine

formation. Food Technol 7(1): 74-79. Song PJ, Hu JF. 1988. N-nitrosamines in

Chinese foods. Food Chem Toxicol 6: 205-208. Spinelli-Gugger AM, Lakritz L,

Wasserman AE, and Gates RA. 1981. Nitrosamine precursors in the adipose tissue

of pork bellies. J Food Sci 46: 1136-1138. Sreekumar Q, Hosono A. 1998a.

Antimutagenicity and the influence of physical factors in binding Lactobacillus

gasseri and Bifidobacterium longum cells to amino acid pyrolysates. J Dairy Sci

81(6): 1508-1516. Sreekumar Q, Hosono A. 1998b. The antimutagenic properties of

a polysaccharide produced by Bifidobacterium longum and its cultured milk against

some heterocyclic amines. Can J Microbiol 44: 1029-1036. Stahnke LH. 1995.

Dried sausages fermented with Staphylococcus xylosus at different temperatures

and with different ingredient levels — Part Ⅰ: Chemical and bacteriological data.

Meat Sci 41: 179-191. Stamer JR. 1979. The lactic acid bacteria: microbes of

diversity. Food Technol 33: 60-65. Steimmetz KA, Potter JD. 1996. Vegetable, fruit

and cancer prevention: a review. J Am Diet Assoc 96: 1027-1039. Sung NJ,

Klausner KA, Hotchkiss JH. 1991. Influence of nitrate, ascorbic acid, and nitrate

reductase microorganisms on N-nitrosamine formation during Korean-style

soysauce fermentation. Food Additives and Contamin 8: 291-298. Surh YJ, Lee RC,

Park KK, Mayne ST, Liem A, Miller JA. 1995. Chemoprotective effects of

capsaicin and diallyl sulfide against mutagensis or tumorigensis by vinyl carbamate

and N-nitrosodimethylamine. Carcinogenesis 16(10): 2467-2671. Tanaka K,

Hayatsu T, Negishi T, Hayatsu H. 1998. Inhibition of N-nitrosation of secondary

amines in vitro by tea extracts and catechins. Mut Res. 412: 91-98. Terracini B,

Magee PN, Barnes JM. 1967. Hepatic pathology in rats on low dietary levels of

dimethylnitrosamine. Br J Cancer 21: 559-564. Thurnham DI. 1990. Anti-oxidant

vitamins and cancer prevention. J Micronutr Anal 7: 279-299. Thyagaraja N,

Hosono A. 1993. Antimutagenicity of lactic acid bacteria from “Idly” against

food-related mutagens. J Food Prot 56(12): 1061-1066. Treptow-van LS,

Rechkemmer G, Rowland IR, Dolara P, Pool-Zobel BL. 1999. The carbohydrate

crystalean and colonic microflora modulate expression of glutathione S-transferase

subunit in colon of rats. Eur J Nutr 38: 76-83. Tricker AR, Preussmann R. 1991.

Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and

carcinogenic potential. Mut Res 259: 277-289. Van den Goorbergh JA, de Wit H,

Tijdens RB, Mulder GJ, Meerman JH. 1987. Prevention by thioethers of the

hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-

acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro.

Carcinogenesis 8(2): 275-279. Vecchio AJ, Hotchkiss JH, Bisogni CA. 1986. N-

nitrosamine ingestion from consumer-cooked bacon. J Food Sci 51: 754-756.

Vittozzi L. 1992. Toxicology of nitrates and nitrites. Food Additives and Contam 9:

579-585. Walker R. 1990. Nitrates, nitrites and N-nitrosocompounds: a review of





the occurrence in food and ddiet and the toxicological implications. Food Additives

and Contam 7: 717-768. Ward FW, Coates ME, Walker R. 1986. Nitrate reduction,

gastro-intestinal pH and N-nitrosation in gnotbiotic and conventional rats. Food

Chem Toxicol 24: 17-22. Wollowski I, Rechkemmer G, Pool-Zobel BL. 2001.

Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr

73(suppl): 451S-455S. Yahagi T, Kagao M, Seino Y, Matsushima T, Sugimura T,

Okada M. 1977. Mutagenicities of N-nitrosaqmines on Salmonella. Mut Res

18:121-130. Yamada M, Matsui K, Sofuni T, Nohmi T. 1997. New tester strains of

Salmonella typhimurium lacking O6-methylguanine DNA methyltransferases and

highly sensitive to mutagenic alkylating agents. Mut Res 381: 15-24. Yang HS,

Dkun JD, Archer MC. 1977. Nonenzymatic microbial acceleration of nitrosamine

formation. J Agric Food Chem 25: 1181-1183. Yukuchi H, Goto T, Okongi S. 1992.

Fermented milks, lactic drinks and intestinal microflora, In “Functions of

Fermented Milk”, Y Nakazawa and A Hosono(Eds), Translated by howells BW,

Elsevier Appl Sci, NY. Zaika LL, Zell TE, Palumbo SA, Smith JL. 1978. Effect of

spices and salt on fermentation of Lebanon bologna type sausage. J Food Sci 43:

186-189. Zeng S, Furr HC, Olson JA. 1992. Metabolism of carotenoid analogs in

human. Am J Clin Nutr 56: 443-449. Zhang XB, Ohta Y. 1991. Binging of

mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J

Dairy Sci 74(5): 1477-1481



論文

頁數


92

附註




全文

點閱

次數






資料

建置

時間






轉檔

日期





全文

檔存

取記








異動

記錄


M admin Y2008.M7.D3 23:17 61.59.161.35

Yüklə 245,71 Kb.

Dostları ilə paylaş:




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©genderi.org 2024
rəhbərliyinə müraciət

    Ana səhifə